IS5044A - Aðferð og ný efnasambönd til að nota með henni - Google Patents

Aðferð og ný efnasambönd til að nota með henni

Info

Publication number
IS5044A
IS5044A IS5044A IS5044A IS5044A IS 5044 A IS5044 A IS 5044A IS 5044 A IS5044 A IS 5044A IS 5044 A IS5044 A IS 5044A IS 5044 A IS5044 A IS 5044A
Authority
IS
Iceland
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
IS5044A
Other languages
English (en)
Inventor
A. Reece Phillip
Geoffrey Watson Keith
Wu Wen-Yang
Jin Betty
Y. Krippner Guy
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO3632A external-priority patent/AUPO363296A0/en
Priority claimed from AUPO8539A external-priority patent/AUPO853997A0/en
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Publication of IS5044A publication Critical patent/IS5044A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Materials Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5044A 1996-11-14 1999-04-30 Aðferð og ný efnasambönd til að nota með henni IS5044A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO3632A AUPO363296A0 (en) 1996-11-14 1996-11-14 Method and novel compounds for use therein
AUPO8539A AUPO853997A0 (en) 1997-08-14 1997-08-14 Method and novel compounds for use therein
PCT/AU1997/000771 WO1998021243A1 (en) 1996-11-14 1997-11-13 Method and novel compounds for use therein

Publications (1)

Publication Number Publication Date
IS5044A true IS5044A (is) 1999-04-30

Family

ID=25645315

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5044A IS5044A (is) 1996-11-14 1999-04-30 Aðferð og ný efnasambönd til að nota með henni

Country Status (19)

Country Link
US (1) US6680054B1 (is)
EP (1) EP0951480A4 (is)
JP (1) JP3691075B2 (is)
KR (1) KR20000068986A (is)
CN (1) CN1238783A (is)
AP (1) AP9901531A0 (is)
AU (1) AU732916C (is)
BR (1) BR9714299A (is)
CA (1) CA2271249C (is)
CZ (1) CZ167999A3 (is)
EA (1) EA001603B1 (is)
HU (1) HUP9904009A3 (is)
IL (1) IL129762A0 (is)
IS (1) IS5044A (is)
NO (1) NO992297L (is)
NZ (1) NZ335368A (is)
PL (1) PL333364A1 (is)
TR (1) TR199901081T2 (is)
WO (1) WO1998021243A1 (is)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US7425541B2 (en) 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030068655A1 (en) * 2001-09-12 2003-04-10 Protiveris, Inc. Microcantilever apparatus and methods for detection of enzymes
AUPR879401A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1853634B1 (en) * 2005-02-23 2016-08-10 Lipoxen Technologies Limited Activated sialic acid derivatives for protein derivatisation and conjugation
WO2009002516A1 (en) * 2007-06-25 2008-12-31 The Administrators Of The Tulane Educational Fund Influenza inhibiting compositions and methods
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5523313B2 (ja) 2007-07-03 2014-06-18 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
JP5702600B2 (ja) * 2007-07-03 2015-04-15 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド オリゴシアル酸誘導体、製造方法および免疫学的使用
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
US20130280204A1 (en) * 2007-08-27 2013-10-24 Massachusetts Institute Of Technology Polymer-Attached Inhibitors of Influenza Virus
US20090076133A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched zanamivir
EP2318832B1 (en) 2008-07-15 2013-10-09 Academia Sinica Glycan arrays on ptfe-like aluminum coated glass slides and related methods
NZ610978A (en) 2009-05-15 2014-11-28 Redx Pharma Ltd Redox drug derivatives
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
PL225045B1 (pl) 2012-05-18 2017-02-28 Univ Jagiellonski Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy
JP6302909B2 (ja) 2012-08-18 2018-03-28 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ シアリダーゼの同定および画像化のための細胞透過性プローブ
US9624272B2 (en) 2013-03-14 2017-04-18 University Of Washington Through Its Center For Commercialization Polypeptides for treating and/or limiting influenza infection
ES2754402T3 (es) 2013-04-01 2020-04-17 Becton Dickinson Co Métodos y kits para el diagnóstico del virus de la gripe
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
US9982041B2 (en) 2014-01-16 2018-05-29 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
US20150344585A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
CN106661099A (zh) 2014-05-27 2017-05-10 中央研究院 抗her2醣抗体及其用途
EP3904388A1 (en) 2014-05-27 2021-11-03 Academia Sinica Fucosidase from bacteroides and methods using the same
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
EP3154582A4 (en) 2014-05-28 2018-01-10 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
CN108473483B (zh) 2015-11-20 2022-08-30 奥斯维尔医疗私人有限公司 用于医药应用的化合物
KR20180114210A (ko) 2016-03-08 2018-10-17 아카데미아 시니카 N-글리칸의 모듈 합성 방법 및 그의 어레이
US10538592B2 (en) 2016-08-22 2020-01-21 Cho Pharma, Inc. Antibodies, binding fragments, and methods of use
MX2021002569A (es) 2018-09-06 2021-06-08 Cidara Therapeutics Inc Composiciones y metodos para el tratamiento de infecciones virales.
TWI861205B (zh) 2019-09-06 2024-11-11 美商席達拉醫療有限公司 用於治療病毒感染之組合物及方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282950B6 (sk) 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
US5221611A (en) 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
WO1994011005A1 (en) 1992-11-09 1994-05-26 Scientific Dimensions Usa, Inc. Viral attachment inhibitors
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
GB9410817D0 (en) 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
CN100409844C (zh) * 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
EP0885391B1 (en) 1996-03-01 2003-04-23 Biota Scientific Management Pty. Ltd. Method of detection of influenza virus and compounds for use therein
AUPO104396A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Also Published As

Publication number Publication date
HUP9904009A2 (hu) 2000-03-28
EP0951480A1 (en) 1999-10-27
JP3691075B2 (ja) 2005-08-31
AU732916C (en) 2002-06-06
JP2001504876A (ja) 2001-04-10
WO1998021243A1 (en) 1998-05-22
CN1238783A (zh) 1999-12-15
NZ335368A (en) 2001-08-31
US6680054B1 (en) 2004-01-20
NO992297L (no) 1999-07-12
NO992297D0 (no) 1999-05-12
HUP9904009A3 (en) 2001-07-30
IL129762A0 (en) 2000-02-29
EP0951480A4 (en) 2004-07-28
KR20000068986A (ko) 2000-11-25
AU4857697A (en) 1998-06-03
CZ167999A3 (cs) 1999-10-13
CA2271249C (en) 2010-07-20
BR9714299A (pt) 2000-04-25
PL333364A1 (en) 1999-12-06
EA199900459A1 (ru) 1999-12-29
AU732916B2 (en) 2001-05-03
EA001603B1 (ru) 2001-06-25
CA2271249A1 (en) 1998-05-22
TR199901081T2 (xx) 1999-08-23
AP9901531A0 (en) 1999-05-13

Similar Documents

Publication Publication Date Title
IS5044A (is) Aðferð og ný efnasambönd til að nota með henni
NO970255D0 (no) Anordning og fremgangsmåte ved avfyringsstyring
NO970762L (no) Brönnstrengskjötlokalisator og fremgangsmåte derved
IS4598A (is) Aðferðir og samsetningar til að stjórna kynsvörunmannsins
DE69714395D1 (de) Abziehvorrichtung
DE69821408D1 (de) Multiplikationsverfahren und -vorrichtung
FI965091A7 (fi) Laskentamenetelmä ja -laite
FI974494L (fi) Paikannusmenetelmä ja paikannusjärjestely
EE03939B1 (et) Portatiivse seadme ekraan ja meetod toiteenergia kokkuhoidmiseks selles seadmes
DE69721286D1 (de) Befestigungsvorrichtung sowie anwendungsverfahren dafür
DE69724347D1 (de) Parallele Datenkomprimierung und -dekomprimierung
DE69703319D1 (de) Schraub-verfahren und -vorrichtung
DE69712234D1 (de) Kodierungsverfahren und -gerät
DE59707845D1 (de) Kryostatmikrotom
FI963172A7 (fi) Kytkentämenetelmä ja laite
DE69916726D1 (de) Kodierungsvorrichtung und -Verfahren
DE59701724D1 (de) Kristallisationsvorrichtung und -verfahren
FI961913L (fi) Näytön tehonsäästömenetelmä
DE69529809D1 (de) Dekodierungsverfahren und -vorrichtung
DE69731574D1 (de) Kompiliergerät und -verfahren
NO20003268D0 (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
DE69820485D1 (de) Dekodierungsverfahren und -vorrichtung
FI971245L (fi) Anti-inflammatorinen tekijä, menetelmä sen eristämiseksi sekä sen käyttö
NO985179D0 (no) FremgangsmÕte og system for tale-til-taleomforming
DK1036319T3 (da) Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf